Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Grant or award Director acquired 647 shares (grant or award)
  2. 4 Open-market sale Director sold 8,600 shares at $6.32 ($54,352)
  3. 4 Open-market sale Director sold 4,689 shares at $6.00 ($28,134)
  4. 4 Grant or award Director acquired 6,820 shares (grant or award)
  5. 4 Grant or award Director acquired 6,820 shares (grant or award)
  6. 4 Grant or award Director acquired 6,820 shares (grant or award)
  7. 4 Grant or award Director acquired 6,820 shares (grant or award)
  8. 4 Grant or award Director acquired 6,820 shares (grant or award)
  9. 4 Open-market sale Director sold 6,698 shares at $6.11 ($40,925)
  10. 4 Grant or award Director acquired 6,820 shares (grant or award)
  11. 4 Grant or award Director acquired 6,820 shares (grant or award)
  12. 4 Grant or award Director acquired 6,820 shares (grant or award)
  13. 4 Grant or award Director acquired 870 shares (grant or award)
  14. 4 Grant or award Director acquired 870 shares (grant or award)
  15. 4 Open-market buy Director bought 7,861 shares at $6.36 ($49,996)
  16. 4 Open-market buy Director bought 2,500 shares at $6.40 ($16,000)
  17. 4 Open-market buy Director bought 5,000 shares at $6.38 ($31,900)
  18. 4 Open-market buy Director bought 15,000 shares at $6.25 ($93,750)
  19. 4 Open-market buy Chief Financial Officer bought 36,300 shares at $5.57 ($202,191)
  20. 4 Open-market buy Chief R&D Officer bought 30,000 shares at $5.86 ($175,800)

Page 5 of 49 · 965 filings